Prostate Cancer Clinical Trial

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Summary

Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Provision of signed and dated informed consent form
Male ≥ 18 years of age

Patients meeting clinical need for Illuccix PET scan:

Patients with suspected metastasis who are candidates for initial definitive therapy
Patients with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
Patient is physically able to lay flat for the PET-CT procedure

Exclusion Criteria:

1. Assessment by the Investigator as unable or unwilling to comply with the requirements of the protocol.

Study is for people with:

Prostate Cancer

Phase:

Early Phase 1

Estimated Enrollment:

100

Study ID:

NCT05558956

Recruitment Status:

Not yet recruiting

Sponsor:

BAMF Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

BAMF Health
Grand Rapids Michigan, 49503, United States More Info
Dan Rogers
Contact
616-330-3886
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Early Phase 1

Estimated Enrollment:

100

Study ID:

NCT05558956

Recruitment Status:

Not yet recruiting

Sponsor:


BAMF Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.